Table 1 Descriptive statistics for sociodemographic and clinical variables of the 21 eligible patients with ovarian cancer at the time of study inclusion before the initiation of adjuvant chemotherapy
| n | % | |||
|---|---|---|---|---|
| Age [in years] |
mean (SD)
range |
52.8 (13.1) 27-74 | ||
| Education | compulsory school or less | 15 | 71% | |
| apprenticeship/professional | 2 | 10% | ||
| school | ||||
| A-level/university | 4 | 19% | ||
| Marital status | single | 1 | 5% | |
| married/with partner | 16 | 75% | ||
| divorced/separated | 2 | 10% | ||
| widowed | 2 | 10% | ||
| Employment status | full employment | 4 | 19% | |
| part-time employment | 6 | 29% | ||
| homemaker | 6 | 29% | ||
| retired/pension | 4 | 19% | ||
| other | 1 | 5% | ||
| Menopausal status | pre-menopausal | 9 | 43% | |
| post-menopausal | 12 | 57% | ||
| FIGO stage | I-II | 6 | 27% | |
| III-IV | 15 | 73% | ||
|
Histological subtype | mucinoid carcinoma | 3 | 14% | |
| serous carcinoma | 16 | 76% | ||
| endometrioid carcinoma | 1 | 5% | ||
| other | 2 | 10% | ||
| Residual disease | none | 7 | 33% | |
| yes | 12 | 57% | ||
| missing | 2 | 10% | ||
|
Chemotherapy regimen | carboplatin/paclitaxel | 20 | 95% | |
| cisplatin/etoposide | 1 | 5% | ||
|
Chemotherapy cycles | 6 | 17 | 81% | |
| 7 | 1 | 5% | ||
| 9 | 3 | 14% | ||
